RenovaroCube announces offering of up to 20% ownership

The Board of Renovaro intends to seek strategic investors to acquire up to 20% of RenovaroCube, currently a wholly owned subsidiary. This opportunity will be available to all potential investors including current shareholders of RENB. Cube is a molecular data science company with a background in FinTech and a 10-year history. It brings together proprietary artificial intelligence technology for multi-omics and multi-modal data analysis, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes, beginning with cancer.